Ascendis Pharma A/S
F:A71
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Ascendis Pharma A/S
F:A71
|
DK |
|
K
|
Kingspan Group PLC
XBER:KRX
|
IE |
|
Teva Pharmaceutical Industries Ltd
F:TEV
|
IL |
|
W
|
Workpoint Entertainment PCL
SET:WORK
|
TH |
Wall St Price Targets
A71 Price Targets Summary
Ascendis Pharma A/S
According to Wall Street analysts, the average 1-year price target for A71 is 236.01 EUR with a low forecast of 199.7 EUR and a high forecast of 287.89 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is A71's stock price target?
Price Target
236.01
EUR
According to Wall Street analysts, the average 1-year price target for A71 is 236.01 EUR with a low forecast of 199.7 EUR and a high forecast of 287.89 EUR.
What is the Revenue forecast for Ascendis Pharma A/S?
Projected CAGR
50%
Over the last 12 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 3 years is 50%.
What is the Gross Profit forecast for Ascendis Pharma A/S?
Projected CAGR
54%
The compound annual growth rate for Gross Profit over the next 3 years is 54%.
